A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer This is a study that will look at the effects and how useful investigational drug olaparib is as a neoadjuvant treatment (treatment given as to shrink a tumor before the main treatment) pr...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study of ENMD-2076 in Ovarian Clear Cell Cancers This is a phase 2 study to see how useful, safe, and tolerable an investigational drug called ENMD-2076 is in treating patients with ovarian clear cell carcinomas. ENMD-2076 is an oral dr...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Ovarian Tumor Biopsies to Study Response to Treatments This is a research study to look at differences in tumor tissue from ovarian cancer patients that may help to determine response and resistance to treatments.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study of Long-Term Responders on Olaparib This is an observational and sample collection study involving patients (alive or deceased) from several clinical trials who had received the investigational drug, olaparib in other resear...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib This is a phase 2 study (the second phase in testing a new drug or drug combination) to see how useful adding investigational drug cediranib to olaparib after disease progression on olapar...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer This is a proof of concept study (a study to initially assess the benefit a new drug indication) of the combination of two investigational drugs cediranib and olaparib in patients with ova...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer This is a phase 2 study whose purpose is to see whether the combination of of pembrolizumab, DPX-Survivac vaccine and low-dose cyclophosphamide has anti-tumor activity in patients with adv...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune